Drug firm Alembic Pharmaceuticals Ltd on Wednesday (February 18) completed an unannounced cGMP inspection by the United States Food and Drug Administration (USFDA) at...
Alembic Pharmaceuticals reported a steady operating performance in Q3, with revenue rising 10.8% year-on-year to ₹1,876.3 crore, supported by consistent execution across domestic and...
Alembic Pharmaceuticals Limited has received tentative approval from the US Food and Drug Administration (USFDA) for its Bosutinib Tablets, 400 mg, the company said...
Pharma major Alembic Pharmaceuticals on Saturday, November 15, announced that it has received final approval from the US Food & Drug Administration (USFDA) for...
Alembic Pharmaceuticals Ltd. on Wednesday, October 29, said it has received the US Food and Drug Administration's (USFDA) final approval for its abbreviated new...